Loading...

CSPC Pharmaceutical Group Limited

CSPCY•PNK
Healthcare
Drug Manufacturers - General
$4.52
$0.14(3.20%)
U.S. Market opens in 7h 53m

CSPC Pharmaceutical Group Limited (CSPCY) Stock Overview

Explore CSPC Pharmaceutical Group Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap13.1B
P/E Ratio56.43
EPS (TTM)$0.20
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$4.77
3 Months$6.33
1 Year Target$6.26

CSPCY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CSPC Pharmaceutical Group Limited (CSPCY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.99, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.26.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 56.43 and a market capitalization of 13.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.20%
5-Day Change
2.73%
1-Month Change
-3.00%
3-Month Change
-11.02%
6-Month Change
14.14%
Year-to-Date (YTD) Change
4.87%
1-Year Change
46.28%
3-Year Change
14.72%
5-Year Change
-10.32%
All-Time (Max) Change
52.19%

Contact Information

https://www.cspc.com.hk
86 31 1870 37015
No. 226 Huanghe Street, Shijiazhuang, NaN, 050035

Company Facts

21,400 Employees
IPO DateMar 25, 2021
CountryCN
Actively Trading

Frequently Asked Questions